Diabetic Ketoacidosis and the Use of New Hypoglycemic Groups: Real-World Evidence Utilizing the Food and Drug Administration Adverse Event Reporting System
Hilal A. Thaibah, Otilia J. F. Banji, D. Banji, T. Alshammari
Pharmaceuticals